Akoya Biosciences Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Brian McKelligon
Chief executive officer
US$2.9m
Total compensation
| CEO salary percentage | 18.6% |
| CEO tenure | 7yrs |
| CEO ownership | 0.08% |
| Management average tenure | 3yrs |
| Board average tenure | 4yrs |
Recent management updates
Recent updates
Market Might Still Lack Some Conviction On Akoya Biosciences, Inc. (NASDAQ:AKYA) Even After 31% Share Price Boost
Jun 27
Is Akoya Biosciences (NASDAQ:AKYA) A Risky Investment?
Jun 24We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Akoya Biosciences, Inc.'s (NASDAQ:AKYA) CEO For Now
May 29Investors Continue Waiting On Sidelines For Akoya Biosciences, Inc. (NASDAQ:AKYA)
May 10Is Akoya Biosciences (NASDAQ:AKYA) Weighed On By Its Debt Load?
Feb 28Investors Still Aren't Entirely Convinced By Akoya Biosciences, Inc.'s (NASDAQ:AKYA) Revenues Despite 31% Price Jump
Nov 25Akoya Biosciences Seeks Growth Despite Higher Operating Losses
May 30Akoya Biosciences, Inc. (NASDAQ:AKYA) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
May 11Akoya Biosciences and AstraZeneca ink collaboration agreement
Jun 04CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$68m |
| Dec 31 2023 | US$3m | US$543k | -US$63m |
| Sep 30 2023 | n/a | n/a | -US$71m |
| Jun 30 2023 | n/a | n/a | -US$76m |
| Mar 31 2023 | n/a | n/a | -US$73m |
| Dec 31 2022 | US$3m | US$518k | -US$71m |
| Sep 30 2022 | n/a | n/a | -US$69m |
| Jun 30 2022 | n/a | n/a | -US$63m |
| Mar 31 2022 | n/a | n/a | -US$51m |
| Dec 31 2021 | US$2m | US$393k | -US$44m |
| Sep 30 2021 | n/a | n/a | -US$34m |
| Jun 30 2021 | n/a | n/a | -US$28m |
| Mar 31 2021 | n/a | n/a | -US$28m |
| Dec 31 2020 | US$516k | US$350k | -US$22m |
| Dec 31 2019 | US$484k | US$333k | -US$18m |
Compensation vs Market: Brian's total compensation ($USD2.92M) is above average for companies of similar size in the US market ($USD683.22K).
Compensation vs Earnings: Brian's compensation has been consistent with company performance over the past year.
CEO
Brian McKelligon (55 yo)
7yrs
Tenure
US$2,919,599
Compensation
Mr. Brian McKelligon has been Chief Executive Officer and Director at Akoya Biosciences, Inc. since July 2017 and also serves as its President. Prior to joining Akoya, he led corporate and business develop...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 7yrs | US$2.92m | 0.075% $ 87.1k | |
| CFO, Principal Financial Officer & Principal Accounting Officer | 1.3yrs | US$2.37m | 0.093% $ 107.0k | |
| Chief Operating Officer | 3.3yrs | US$1.21m | 0.061% $ 70.8k | |
| Senior Director of Business Development & Investor Relations Strategy | no data | no data | no data | |
| General Counsel | 1.4yrs | no data | 0.012% $ 14.3k | |
| Chief Business Officer | 3.9yrs | US$365.22k | 0.29% $ 338.8k | |
| Senior Vice President | 2.8yrs | no data | no data | |
| Secretary | no data | no data | no data |
3.0yrs
Average Tenure
53yo
Average Age
Experienced Management: AKYA's management team is considered experienced (3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 7yrs | US$2.92m | 0.075% $ 87.1k | |
| Independent Chairman | 8.7yrs | US$251.66k | 0.75% $ 864.8k | |
| Independent Director | 2.8yrs | US$237.50k | 0.041% $ 46.8k | |
| Independent Director | 4.8yrs | US$220.00k | 0% $ 0 | |
| Director | 8.7yrs | US$210.00k | 0.48% $ 548.9k | |
| Independent Director | 7yrs | US$232.50k | 1.99% $ 2.3m | |
| Member of Scientific Advisory Board | less than a year | no data | no data | |
| Independent Director | 3.1yrs | US$250.00k | 0.058% $ 66.7k | |
| Member of Scientific Advisory Board | less than a year | no data | no data | |
| Chair of the Scientific Advisory Board | less than a year | US$220.00k | 1.25% $ 1.4m |
4.0yrs
Average Tenure
66yo
Average Age
Experienced Board: AKYA's board of directors are considered experienced (4 years average tenure).